Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Guaifenesin

U.S. FDA Requirements: Guaifenesin

Pharmaceutical / Drug Definition : Exerts vasoconstrictive action that leads to decreased edema and congestion. Also increases respiratory secretions and reduces mucus viscosity.

In the United States, Guaifenesin is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Guaifenesin.

Registrar Corp assists Guaifenesin companies with:

  • FDA Registration Guaifenesin
  • FDA Listing Guaifenesin
  • FDA Label Requirements and Exceptions Guaifenesin
  • FDA Import Information Guaifenesin
  • FDA Detentions Guaifenesin (Guaifenesin Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Guaifenesin (Guaifenesin Suppliers)
       - Processors Guaifenesin
       - Repackers Guaifenesin
       - Relabelers Guaifenesin
       - Exporters Guaifenesin
       - Importers Guaifenesin
For more information about Guaifenesin, simply click below:

Live Help

U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207

Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2017 Registrar Corp
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco